financetom
Business
financetom
/
Business
/
Update: FTC to Block Tempur Sealy Acquisition of Retailer Mattress Firm
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: FTC to Block Tempur Sealy Acquisition of Retailer Mattress Firm
Jul 2, 2024 10:45 AM

01:27 PM EDT, 07/02/2024 (MT Newswires) -- (Updates with details throughout.)

The US Federal Trade Commission has voted to block Tempur Sealy International's ( TPX ) $4 billion acquisition of Mattress Firm, the regulator said Tuesday.

The Commission voted 5-0 to challenge the deal, saying it would give Tempur Sealy ( TPX ) "the ability and incentive to suppress competition and raise prices for mattresses for millions of consumers."

The regulator said it has issued an administrative complaint and authorized a lawsuit in federal court to block the transaction.

"Through emails, presentations, and other deal documents, Tempur Sealy ( TPX ) has made it abundantly clear that its acquisition of Mattress Firm is intended to kneecap competitors and dominate the market," Henry Liu, director of FTC Bureau of Competition said.

Tempur Sealy ( TPX ) said in a separate statement that FTC's decision does not reflect all the relevant facts and regulations. The company expects to complete the litigation process in the coming months and aims to close the deal in late 2024 or early 2025.

The FTC's decision to block the deal was earlier reported by Reuters.

Mattress Firm did not immediately respond to MT Newswires' requests for comment.

Price: 48.39, Change: +1.18, Percent Change: +2.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved